HIF1A and glioblastoma: An in vitro study using patient-derived xenograft recurrent GBM models demonstrated that treatment with TMZ induces HIF-1α and HIF-2α expression that coincides with real-time observation of de-differentiation of non-GSC tumor cells to stem-like cells [58].